MPM ASSET MANAGEMENT LLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 54 filers reported holding HARPOON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
MPM ASSET MANAGEMENT LLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,261,938
-43.2%
313,136
-90.0%
0.68%
-38.0%
Q2 2023$2,223,285
-4.6%
3,131,3880.0%1.09%
+12.3%
Q1 2023$2,329,753
+2.5%
3,131,3880.0%0.97%
+2.1%
Q4 2022$2,273,388
-25.1%
3,131,3880.0%0.95%
-17.8%
Q3 2022$3,037,000
-49.2%
3,131,3880.0%1.16%
-54.2%
Q2 2022$5,981,000
-61.6%
3,131,3880.0%2.52%
-52.5%
Q1 2022$15,563,000
-34.2%
3,131,3880.0%5.32%
+4.1%
Q4 2021$23,642,000
-4.4%
3,131,3880.0%5.11%
-10.9%
Q3 2021$24,738,000
-43.0%
3,131,388
+0.0%
5.73%
-29.0%
Q2 2021$43,417,000
-35.9%
3,130,267
-3.3%
8.07%
-38.3%
Q1 2021$67,745,000
-9.9%
3,238,306
-28.4%
13.09%
+23.1%
Q4 2020$75,151,000
-2.2%
4,524,4250.0%10.64%
-25.8%
Q3 2020$76,870,000
+2.4%
4,524,4250.0%14.33%
-35.9%
Q2 2020$75,105,000
+43.3%
4,524,4250.0%22.35%
-29.9%
Q1 2020$52,393,000
-21.7%
4,524,4250.0%31.87%
+8.2%
Q4 2019$66,916,000
+8.3%
4,524,4250.0%29.45%
+11.4%
Q3 2019$61,804,000
+5.1%
4,524,4250.0%26.45%
+11.3%
Q2 2019$58,818,000
+37.3%
4,524,4250.0%23.77%
+34.5%
Q1 2019$42,846,0004,524,42517.67%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$66,038,00015.37%
MPM ASSET MANAGEMENT LLC 3,238,306$67,745,00013.09%
MPM BioImpact LLC 3,898,422$81,555,00010.25%
Aquilo Capital Management, LLC 1,554,199$32,514,0005.88%
Altium Capital Management LP 199,607$4,176,0001.16%
SECTORAL ASSET MANAGEMENT INC 631,050$13,202,0001.00%
Avidity Partners Management LP 1,408,000$29,455,0000.81%
DAFNA Capital Management LLC 126,663$2,650,0000.63%
Logos Global Management LP 300,000$6,276,0000.61%
Orbimed Advisors 2,285,704$47,817,0000.45%
View complete list of HARPOON THERAPEUTICS INC shareholders